The deal will open the door for the company to tap into an archive of more than 2,000 designs by Key West Hand Print Fabrics ...
FOX 35's David Martin visits a home in Winter Garden inspired by Lilly Pulitzer & Christmas.
The model has also starred in campaigns for Dior, Dolce & Gabbana, Ungaro, H&M, Anna Sui, Lilly Pulitzer and Guess. And she has landed on the covers of Vogue and Elle. A source told The Sun ...
The FDA confirmed on Thursday that Eli Lilly’s tirzepatide, marketed as Zepbound for weight loss, is no longer in shortage, multiple outlets reported. The agency added that it will give compounders 60 ...
Eli Lilly has become one of the world's most influential pharmaceutical companies. That's thanks to its weight-loss medications, but it has other opportunities now as well. A recent announcement ...
Sydney Sweeney’s bikini collection is seriously coveted. Sweeney, 27, rocked a lavender swimsuit while escaping the winter chill and tanning in Florida Keys on Saturday, December 7. Her suit ...
The increase in gross margin was primarily due to a $4 million lower LIFO accounting charge and lower discounts at Lilly Pulitzer. This was partially offset due to full-price retail and e-commerce ...
(Bloomberg) -- Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, ...
BACKGRID Cindy Crawford brought her sexiest swimsuits - and some supermodel energy - on winter vacation. The supermodel was recently spotted on the beach in Cancun, Mexico, looking ageless as she ...
Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug addiction, making it the first major ...
Eli Lilly will launch Mounjaro in India in 2025. The drug treats type 2 diabetes and obesity. Lilly received marketing authorization in July. It is working on additional approvals. Mounjaro's global ...
(Bloomberg) — Eli Lilly & Co. approved a program to buy back as much as $15 billion of its own shares amid rapid growth fueled in part by the blockbuster weight-loss drug Zepbound. The company ...